Matthew Johnson
Matthew Johnson, director of access and innovation, Roche Diagnostics UK & Ireland
HSJ PartnersDementia diagnosis: why patients can’t wait for the future
The government’s new vision for dementia diagnosis is ambitious: by 2029, more than 92 per cent of patients could receive a diagnosis within 18 weeks of referral, up from fewer than half today.